تاثیر مکمل رزوراتول طی تمرینات ورزشی بازتوانی قلبی بر نیم رخ لیپیدی بیماران قلبی تحت عمل جراحی بای پس: کارآزمایی بالینی تصادفی شده

World health organization. Cardiovascular disease mediacenterel, 311-171.

Mozafari A, Hejazi SF, Baharvand A, Marvi M, Olomi Doran V, Mohebi S, Gharebeigloo M. The effect of cardiac rehabilitation on the results of 6-minute walk test in post angioplasty cardiac patients referred to Shahid Beheshti Hospital in Qom city, Iran. Qom Univ Med Sci J 2015;9:41-7.[Persian].

Zordoky BN, Robertson IM, Dyck JR. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta 2015; 1852:1155-77. doi: 10.1016/j.bbadis.2014.10.016

Shabani R, Mozaffari M, Heidari Moghadam R, Shirmohamadi T, Vafaee R. Effect of cardiac rehabilitation program on quality of life in patients with myocardial infarction in Hamadan. Research in Medicine 2013;36:117-22.

Wang H, Yang Y, Qian HY, Zhang Q, Xu H, Li JJ. Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev 2012;17:437-48. doi: 10.1007/s10741-011-9260-4

Franklin BA, Whaley MH, Howley ET, Balady GJ, ACSM. ACSM's guidelines for exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins, 2006; 112-119.

Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 2011;1215:22-33. doi: 10.1111/j.1749-6632.2010.05843.x

Liu X, Tian J, Bai Q, Ashraf MA, Sarfraz M, Zhao B. The effect and action mechanism of resveratrol on the vascular endothelial cell by high glucose treatment. Saudi J Biol Sci 2016; 23:S16-21. doi: 10.1016/j.sjbs.2015.06.021

Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23.

Adams J, Cline M, Reed M, Masters A, Ehlke K, Hartman J. Importance of resistance training for patients after a cardiac event. Proc (Bayl Univ Med Cent) 2006;19:246-8.

Hong SW, Jung KH, Zheng HM, Lee HS, Suh JK, Park IS, et al. The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats. Arch Pharm Res 2010;33:601-9. doi: 10.1007/s12272-010-0415-y

Faghihzadeh F, Adibi P, Hekmatdoost A. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. Br J Nutr 2015;14;114:796-803. doi: 10.1017/S0007114515002433

Van der Made SM, Plat J, Mensink RP. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLoS One 2015;19:10:e0118393. doi: 10.1371/journal.pone.0118393

Zortea K , Franco VC, Francesconi LP , Cereser KM, Lobato MI, Belmonte-de-Abreu PS. Resveratrol supplementation in schizophrenic patients: a randomized clinical trial evaluating serum glucose and cardiovascular risk factors. Nutrients 2016;8:73. doi: 10.3390/nu8020073

Fullerton MD, Steinberg GR. SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes 2010;59:551-3. doi: 10.2337/db09-1732